Published online before print March 16, 2006, doi: 10.1161/01.RES.0000217402.73402.cd
© 2006 American Heart Association, Inc.
Clinical Research |
Positive Inotropic Effects by Uridine Triphosphate (UTP) and Uridine Diphosphate (UDP) via P2Y2 and P2Y6 Receptors on Cardiomyocytes and Release of UTP in Man During Myocardial Infarction
From the Departments of Cardiology (A.-K.W., L.W., C.B., D.E.) and Experimental Medical Science (J.B., A.A.), Lund University, Sweden; the Molecular Recognition Section (B.V.J., K.A.J.), National Institutes of Health, Bethesda, Md; the Department of Medicine (E.L.), University of North Carolina, School of Medicine, Chapel Hill; and the Department of Physiology and Pharmacology (Y.D., A.A.), Karolinska Institutet, Stockholm, Sweden.
Correspondence to Dr Anna-Karin Wihlborg, Department of Cardiology, Tornavägen 10 BMC:C12, Lund 22237, Sweden. E-mail anna-karin.wihlborg{at}kard.lu.se
The aim of this study was to examine a possible role for extracellular pyrimidines as inotropic factors for the heart. First, nucleotide plasma levels were measured to evaluate whether UTP is released in patients with coronary heart disease. Then, inotropic effects of pyrimidines were examined in isolated mouse cardiomyocytes. Finally, expression of pyrimidine-selective receptors (a subgroup of the P2 receptors) was studied in human and mouse heart, using real time polymerase chain reaction, Western blot, and immunohistochemistry. Venous plasma levels of UTP were increased (57%) in patients with myocardial infarction. In electrically stimulated cardiomyocytes the stable P2Y2/4 agonist UTP
S increased contraction by 52%, similar to ß1-adrenergic stimulation with isoproterenol (65%). The P2Y6-agonist UDPßS also increased cardiomyocyte contraction (35%), an effect abolished by the P2Y6-blocker MRS2578. The phospholipase C inhibitor U73122 inhibited both the UDPßS and the UTPS-induced inotropic effect, indicating an IP3-mediated effect via P2Y6 receptors. The P2Y14 agonist UDP-glucose was without effect. Quantification of mRNA with real time polymerase chain reaction revealed P2Y2 as the most abundant pyrimidine receptor expressed in cardiomyocytes from man. Presence of P2Y6 receptor mRNA was detected in both species and confirmed at protein level with Western blot and immunohistochemistry in man. In conclusion, UTP levels are increased in humans during myocardial infarction, giving the first evidence for UTP release in man. UTP is a cardiac inotropic factor most likely by activation of P2Y2 receptors in man. For the first time we demonstrate inotropic effects of UDP, mediated by P2Y6 receptors via an IP3-dependent pathway. Thus, the extracellular pyrimidines (UTP and UDP) could be important inotropic factors involved in the development of cardiac disease.
Key Words: P2-receptors • inotropy • heart • UTP • UDP
This article has been cited by other articles:
 |
|
 |
|
  T. Moore-Morris, A. Varrault, M. E. Mangoni, A. Le Digarcher, V. Negre, C. Dantec, L. Journot, J. Nargeot, and B. Couette Identification of Potential Pharmacological Targets by Analysis of the Comprehensive G Protein-Coupled Receptor Repertoire in the Four Cardiac Chambers Mol. Pharmacol., May 1, 2009; 75(5): 1108 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Rosenmeier, G. G. Yegutkin, and J. Gonzalez-Alonso Activation of ATP/UTP-selective receptors increases blood flow and blunts sympathetic vasoconstriction in human skeletal muscle J. Physiol., October 15, 2008; 586(20): 4993 - 5002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Alvarez, A. Coulombe, O. Cazorla, M. Ugur, J.-M. Rauzier, J. Magyar, E.-L. Mathieu, G. Boulay, R. Souto, P. Bideaux, et al. ATP/UTP activate cation-permeable channels with TRPC3/7 properties in rat cardiomyocytes Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H21 - H28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. P. Fricks, S. Maddileti, R. L. Carter, E. R. Lazarowski, R. A. Nicholas, K. A. Jacobson, and T. K. Harden UDP Is a Competitive Antagonist at the Human P2Y14 Receptor J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 588 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Gergs, P. Boknik, W. Schmitz, A. Simm, R.-E. Silber, and J. Neumann A positive inotropic effect of ATP in the human cardiac atrium Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1716 - H1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Domeier, A. V. Zima, J. T. Maxwell, S. Huke, G. A. Mignery, and L. A. Blatter IP3 receptor-dependent Ca2+ release modulates excitation-contraction coupling in rabbit ventricular myocytes Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H596 - H604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wee, J. N. Peart, and J. P. Headrick P2 Purinoceptor-Mediated Cardioprotection in Ischemic-Reperfused Mouse Heart J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 861 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Dou, P. Arlock, and A. Arner Blebbistatin specifically inhibits actin-myosin interaction in mouse cardiac muscle Am J Physiol Cell Physiol, September 1, 2007; 293(3): C1148 - C1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Winter and K. A. Dora Spreading dilatation to luminal perfusion of ATP and UTP in rat isolated small mesenteric arteries J. Physiol., July 1, 2007; 582(1): 335 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jalvy, M.-A. Renault, L. Lam Shang Leen, I. Belloc, A. Reynaud, A.-P. Gadeau, and C. Desgranges CREB Mediates UTP-Directed Arterial Smooth Muscle Cell Migration and Expression of the Chemotactic Protein Osteopontin via Its Interaction with Activator Protein-1 Sites Circ. Res., May 11, 2007; 100(9): 1292 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Burnstock Physiology and Pathophysiology of Purinergic Neurotransmission Physiol Rev, April 1, 2007; 87(2): 659 - 797. [Abstract] [Full Text] [PDF]
|
|